 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
Deletion? Not yet! edit
I wanted to address the request for deletion on the AURORA trial on the grounds that it is not a notable clinical trial. First of all, it was only published in print YESTERDAY (still not available on the online New England Journal of Medicine) - give it a few weeks to make a splash. Secondly, I disagree that it isn't notable. Statins (of which rosuvastatin is a member), are widely prescribed medications and are considered standard of care in diabetics and in patients with other cardiovascular risk factors. This trial has the potential to change clinical practice for a large patient population; the financial implications of this study are potentially huge. Give it time, then revisit. Wawot1 (talk) 21:53, 1 April 2009 (UTC)
Lots of news stories out there:
http://www.reuters.com/article/marketsNews/idINN3035840720090330?rpc=44
http://online.wsj.com/article/BT-CO-20090330-711056.html